V. Hadrava

发表

Abnormalities in Growth Characteristics of Aortic Smooth Muscle Cells in Spontaneously Hypertensive Rats

P. Hamet, J. Tremblay, V. Hadrava, 1989, Hypertension.

Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension.

P. Hamet, J. Tremblay, Y. Lacourciére, 1991, American heart journal.

Transforming Growth Factor px Expression and Effect in Aortic Smooth Muscle Cells From Spontaneously Hypertensive Rats

P. Hamet, J. Tremblay, V. Hadrava, 1991 .

Vascular smooth muscle cell hyper‐responsiveness to growth factors in hypertension

P. Hamet, J. Tremblay, V. Hadrava, 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Intrinsic factors involved in vascular smooth muscle cell proliferation in hypertension.

P. Hamet, J. Tremblay, V. Hadrava, 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

Enhanced growth-dependent expression of TGF beta 1 and hsp70 genes in aortic smooth muscle cells from spontaneously hypertensive rats.

P. Hamet, J. Tremblay, V. Hadrava, 1992, Canadian journal of physiology and pharmacology.

Agonist occupation of serotonin1a receptors in the rat hippocampus prevents their inactivation by pertussis toxin

C. Montigny, P. Blier, V. Hadrava, 1994, Neuroscience.

Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into the S phase of the cell cycle.

R. Sékaly, P. Hamet, J. Tremblay, 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Transforming growth factor beta 1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats.

P. Hamet, J. Tremblay, P Hamet, 1991, Hypertension.

Characterization of 5-hydroxytryptamine1A properties of flesinoxan: In Vivo electrophysiology and hypothermia study

C. Montigny, P. Blier, V. Hadrava, 1995, Neuropharmacology.

Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors.

C. de Montigny, P. Blier, V. Hadrava, 1996, Journal of psychiatry & neuroscience : JPN.

Sertraline and Fluoxetine Treatment of Obsessive-Compulsive Disorder: Results of a Double-Blind, 6-Month Treatment Study

R. Swinson, A. Ravindran, R. Bergeron, 2002, Journal of clinical psychopharmacology.

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

R. Bowen, R. Swinson, J. Walker, 2001, The American journal of psychiatry.

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.

R. Bowen, R. Swinson, J. Walker, 2000, Journal of clinical psychopharmacology.

Sertraline and fluoxetine treatment of OCD: a 6-month, double-blind, parallel study

R. Bergeron, V. Hadrava, R. Ravindran, 2000, European Neuropsychopharmacology.